Julie O’Brien

510 total citations
14 papers, 404 citations indexed

About

Julie O’Brien is a scholar working on Economics and Econometrics, Physiology and Immunology. According to data from OpenAlex, Julie O’Brien has authored 14 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Economics and Econometrics, 4 papers in Physiology and 4 papers in Immunology. Recurrent topics in Julie O’Brien's work include Biomedical Ethics and Regulation (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Biosimilars and Bioanalytical Methods (4 papers). Julie O’Brien is often cited by papers focused on Biomedical Ethics and Regulation (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Biosimilars and Bioanalytical Methods (4 papers). Julie O’Brien collaborates with scholars based in United States, United Kingdom and Ireland. Julie O’Brien's co-authors include Dermot Kelleher, Matthew S. McCabe, Verónica Athié-Morales, Ena Singh, Brian Fitzpatrick, Ehab Mahgoub, Christine E. Loscher, Luke O'neill, Oliver Morton and Déirdre Ní Eidhin and has published in prestigious journals such as PLoS Pathogens, Journal of Autism and Developmental Disorders and FEMS Microbiology Letters.

In The Last Decade

Julie O’Brien

14 papers receiving 391 citations

Peers

Countries citing papers authored by Julie O’Brien

Since Specialization

Citations

This map shows the geographic impact of Julie O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie O’Brien more than expected).

Fields of papers citing papers by Julie O’Brien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie O’Brien. The network helps show where Julie O’Brien may publish in the future.

Co-authorship network of co-authors of Julie O’Brien

This figure shows the co-authorship network connecting the top 25 collaborators of Julie O’Brien. A scholar is included among the top collaborators of Julie O’Brien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie O’Brien. Julie O’Brien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Regulatory agilities impacting review timelines for Pfizer/BioNTech’s BNT162b2 mRNA COVID-19 vaccine: a retrospective study 2023 ·Frontiers in Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jinma Ren, Haitao Chu, Joseph C. Cappelleri, Satrajit Roychoudhury, Julie O’Brien, (unknown), (unknown)	4
2	Strengthening regulatory systems for medicines in a changed world: where do we go from here? 2021 ·BMJ Global Health ·Julie O’Brien, (unknown), (unknown)	8
3	Building a Better Approach for the Benefit of Patients: 10 Pillars to Strengthen Regulatory Review Systems Globally 2020 ·Therapeutic Innovation & Regulatory Science ·Julie O’Brien, (unknown), (unknown), (unknown)	10
4	Building a Better Approach for the Benefit of Patients: 10 Pillars to Strengthen Regulatory Review Systems Globally 2019 ·Therapeutic Innovation & Regulatory Science ·Julie O’Brien, (unknown), (unknown), (unknown)	3
5	Variability of intended copies for etanercept (Enbrel®): Data on multiple batches of seven products 2017 ·mAbs ·(unknown), Morton Scheinberg, Gilberto Castañeda‐Hernández, Mengtao Li, (unknown), Ena Singh, Ehab Mahgoub, Javier Coindreau, Julie O’Brien, (unknown), Brian Fitzpatrick	23
6	Transition tools and access to adult primary care 2017 ·Advances in Autism ·Marji Erickson Warfield, Morgan K. Crossman, Ann M. Neumeyer, Julie O’Brien, Karen Kuhlthau	1
7	Manufacturing history of etanercept (Enbrel^®): Consistency of product quality through major process revisions 2017 ·mAbs ·(unknown), Ena Singh, Ehab Mahgoub, Julie O’Brien, (unknown), Brian Fitzpatrick	30
8	Brief Report: Autism Spectrum Disorder and Substance Use Disorder: A Review and Case Study 2016 ·Journal of Autism and Developmental Disorders ·(unknown), James McKowen, Julie O’Brien, Yamini J. Howe, Christopher J. McDougle	26
9	Differentiating biosimilarity and comparability in biotherapeutics 2016 ·Clinical Rheumatology ·Valderílio Feijó Azevedo, (unknown), João Eurico Fonseca, Tatsuya Atsumi, Javier Coindreau, Ira Jacobs, Ehab Mahgoub, Julie O’Brien, Ena Singh, (unknown), Brian Fitzpatrick	26
10	A Role for TLR4 in Clostridium difficile Infection and the Recognition of Surface Layer Proteins 2011 ·PLoS Pathogens ·Anthony W. Ryan, Mark Lynch, Sinéad M. Smith, Sylvie Amu, Hendrik J. Nel, Claire E. McCoy, Jennifer K. Dowling, Eve Draper, Vincent O’Reilly, (unknown), Julie O’Brien, Déirdre Ní Eidhin, Mary J. O’Connell, Brian Keogh, Oliver Morton, Thomas R. Rogers, Padraic G. Fallon, Luke O'neill, Dermot Kelleher, Christine E. Loscher	156
11	Active immunization of hamsters againstClostridium difficileinfection using surface-layer protein 2008 ·FEMS Immunology & Medical Microbiology ·(unknown), Julie O’Brien, Matthew S. McCabe, Verónica Athié-Morales, Dermot Kelleher	55
12	The role of leadership in HRH development in challenging public health settings 2008 ·Human Resources for Health ·(unknown), Julie O’Brien, (unknown), (unknown)	10
13	Passive immunisation of hamsters againstClostridium difficileinfection using antibodies to surface layer proteins 2005 ·FEMS Microbiology Letters ·Julie O’Brien, Matthew S. McCabe, (unknown), G. S. A. McDonald, (unknown), Dermot Kelleher	37
14	The Relationship Between Club Drug Use and Other Drug Use: A Survey of New York City Middle School Students 2005 ·Substance Use & Misuse ·Lloyd A. Goldsamt, Julie O’Brien, Michael C. Clatts, (unknown)	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact